Privacy Law and I.P.: Key Issues and Intersections
Privacy law and intellectual property law are two distinct yet increasingly interconnected areas of U.S. law. While I.P. protects creative and innovative works, privacy law protects personal...
Privacy law and intellectual property law are two distinct yet increasingly interconnected areas of U.S. law. While I.P. protects creative and innovative works, privacy law protects personal...
The culinary world presents unique challenges when it comes to intellectual property protection. While chefs, food bloggers, and recipe developers invest considerable creativity and effort into their...
In our increasingly digital world, data extraction and analysis have become fundamental to how businesses operate, researchers conduct studies, and AI systems learn. Two key concepts at the heart of...
Section 101 of the Patent Act, establishes the foundation for what constitutes patentable subject matter in the United States. The seemingly straightforward language – “Whoever invents or discovers...
Patent law can be complex and overwhelming, even for experienced practitioners. In re Donald K. Forest issued by the Court of Appeals for the Federal Circuit highlights one of these challenging...
Consistent with its previous fee study authorized by Congress in 2022, the U.S. Patent and Trademark Office (USPTO) is increasing patent fees on a long list of categories. The study culminated in an...
The Tax & Trade Bureau of the U.S. Department of the Treasury has approved four new American Viticultural Areas (AVAs) this year: Contra Costa, Comptche, Yucaipa Valley, and Upper Cumberland. The...
On May 18, 2023, the U.S. Supreme Court released its long-awaited decision in Amgen Inc. v. Sanofi, which touches on a formal requirement for patentability, the enablement requirement. In a...
U.S. Patent No. PP35,001 P3 (‘001) issued on February 28, 2023 for “Blueberry Plant Named ‘C15-270’.” It was issued to inventors Jessica Scalzo & James W. Olmestead and applicants/assignees Costa...
On February 13, 2023, in ChromaDex, Inc. v. Elysium Health, Inc., the Court of Appeals for the Federal Circuit issued its first opinion of the year dealing with patent eligibility under 35 U.S.C....